載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$4.15
US$0.00 · 0.00%
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
前收盤價
US$4.15
US$0.00 · 0.00%
盤前
US$4.78
+US$0.63 · +15.18%
10月12日 上午4:00 ET
盤中時間採用ET。市場資料可能有所延遲。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日內區間
目前US$4.15
52週區間
目前US$4.15
盤中時間採用ET。市場資料可能有所延遲。
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
日內區間
目前US$4.15
52週區間
目前US$4.15
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1785.87萬 USD | 2302.45萬 USD | 3230.87萬 USD | 4014.32萬 USD | 4798.2萬 USD |
| 銷貨成本 | 1155.76萬 USD | 1695.26萬 USD | 2199.36萬 USD | 1825.18萬 USD | 2265.59萬 USD |
| 毛利 | 630.12萬 USD | 607.19萬 USD | 1031.51萬 USD | 2189.13萬 USD | 2532.62萬 USD |
| 研究與開發 | 67.18萬 USD | 303.11萬 USD | 485.85萬 USD | 762.33萬 USD | 546.57萬 USD |
| 銷售、一般及管理費用 | 800.24萬 USD | 1044.44萬 USD | 900.09萬 USD | 2129.5萬 USD | 627.04萬 USD |
| 營業費用 | 921.71萬 USD | 1409.17萬 USD | 1384.19萬 USD | 2891.08萬 USD | 1173.6萬 USD |
| 利息支出 | 23.2萬 USD | 27.82萬 USD | 15.68萬 USD | 16.24萬 USD | 10.16萬 USD |
| 折舊和攤銷 | 51.74萬 USD | 48.57萬 USD | 50.88萬 USD | 53.39萬 USD | 44.69萬 USD |
| 營業利益 | −291.59萬 USD | −801.98萬 USD | −352.68萬 USD | −701.94萬 USD | 1359.01萬 USD |
| 淨利 | −367.21萬 USD | −872.73萬 USD | −616.31萬 USD | −873.66萬 USD | 1132萬 USD |
公司資料更新於 2026年10月12日。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
